Studies backed propranolol in treating infantile hemangioma

Two new studies underscore the important role of oral propranolol in the first-line treatment of infantile hemangioma (IH), as well as the need for better long-term data on the safety of the beta-blocker in very young children, according to the authors. In the first study, an uncontrolled...
Source: Skin and Allergy News - Category: Dermatology Source Type: news